Ontario Bioscience Innovation Organization (OBIO), a non-profit organization that is Ontario’s leading advocate for the life sciences sector, is pleased to announce a call for applications for the third cycle of the OBIO Capital Access Advisory Program (CAAPTM).

OBIO CAAP is an industry-led program that works to improve access to capital for Ontario bioscience companies. It is a unique program that provides companies with mentoring, strategic guidance and access to the networks from both senior members of the life science venture capital community and senior advisors from industry to prepare companies to seek capital. Through OBIO CAAP, the Organization helps to advance the development and commercialization of medical devices, drugs and other life science technologies that can improve the lives of people in Ontario and around the world.

OBIO CAAP Eligibility

  • Companies focused on developing life science products or services including but not limited to therapeutics, medical devices, diagnostics, or healthcare information technologies; and
  • Enterprises that have already raised initial capital and are committed to raising an additional “Series A” or later round of financing in the next 12 to 18 months.

Information Session and Applications

An information session for companies that want to apply to OBIO CAAP will be held on December 11, 2014, at 11 am ET by teleconference. To register, please email CAAP@OBIO.ca.

Additional information on OBIO CAAP can be found at www.obio.ca. Applications are available by sending an email to CAAP@OBIO.ca. Applications must be received by January 16, 2015, at 5 pm ET.